• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

ImmunoBiology Ltd (ImmBio) - Articles and news items

PnuBioVax

Pneumococcal vaccine PnuBioVax safe and immunogenic in Phase I study

Industry news / 30 June 2016 / Victoria White, Digital Content Producer

ImmBio has reported positive results from the First-in-Human study of its novel vaccine, PnuBioVax, against the bacterial pathogen Streptococcus pneumoniae…

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +